Hantz Financial Services, Inc. Cytokinetics Inc Transaction History
Hantz Financial Services, Inc.
- $6.6 Billion
- Q3 2025
A detailed history of Hantz Financial Services, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 4,613 shares of CYTK stock, worth $306,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,613
Previous 1,308
252.68%
Holding current value
$306,487
Previous $43,000
490.7%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
451Shares Held
129MCall Options Held
5.25MPut Options Held
1.18M-
T. Rowe Price Investment Management, Inc. Baltimore, MD19.1MShares$1.27 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$788 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.41MShares$492 Million0.07% of portfolio
-
State Street Corp Boston, MA5.62MShares$373 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $6.25B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...